SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide | 9359P

SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide | 9359P | Gentaur UK, US & Europe Distribution

Short Description: SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide

Species: SARS-CoV-2

Location: 12 amino acids near the center of SARS-CoV-2 UK variant (B.1.1.7) Spike protein

Tested Application: Bl

Application: SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H is used for blocking the activity of the SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody.

Physical State: Liquid

Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

Concentration: 200 ug/mL

Storage: Store SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H at -20˚C, stable for one year.

NCBI Official Symbol: S

Alternate Names: SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein

NCBI Gene ID: 43740568

User Note: N/A

NCBI Official Name: Surface Glycoprotein

Background: Duchene et al. Virus Evolution 6(2): veaa061.

Disclaimer: This product is for research use only.